Cardiac Safety of mRNA-Based Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Disorders with a History of Myocarditis

Cardiac Safety of mRNA-Based Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Disorders with a History of Myocarditis

Anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines may trigger immune-mediated adverse events, including myocarditis. Evidence of vaccine safety in patients with rheumatic disorders and underlying autoimmune myocarditis is scarce. To address this issue, we studied 13 patients...

Full description

Bibliographic Details
Main Authors: Giuseppe A. Ramirez, Veronica Batani, Luca Moroni, Giacomo De Luca, Giuseppe Pizzetti, Simone Sala, Giovanni Peretto, Corrado Campochiaro, Emanuel Della-Torre, Enrica P. Bozzolo, Lorenzo Dagna
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Pathogens
Subjects:
myocarditis
severe acute respiratory syndrome coronavirus 2
vaccines
systemic lupus erythematosus
adverse event
disease flare
Online Access:https://www.mdpi.com/2076-0817/11/9/1001

Internet

https://www.mdpi.com/2076-0817/11/9/1001

Similar Items